In this single-center ambispective cohort of 283 Polish patients with COVID-19–related ARDS requiring invasive mechanical ventilation, cumulative mortality reached 44.5% at four years after ICU ...

If approved, Moderna's mCOMBRIAX would become the first combination Covid-flu jab to gain regulatory approval anywhere across ...

A Finnish national turned a two-week trip into a new career, and now manages high-end listings in one of the world’s top real ...

COMBRIAX is the world's first flu plus COVID combination vaccine to receive a positive CHMP opinion recommending ...

If the recommendation is accepted by the European Commission, Moderna's mCombriax vaccine will be available for adults 50 and older throughout the European Union.

The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be ...

European regulators cleared Moderna’s first-of-its-kind vaccine as US approval remains uncertain. On Friday, Moderna’s ...

Co-infection of influenza virus and SARS-CoV-2 can lead to more severe disease than infection of either alone.

In issuing a positive recommendation, the EMA has diverged from the FDA, which has set higher approval standards for ...

A new global systematic review and meta-analysis finds that over 40% of health care workers experienced insomnia during and after the acute phase of the COVID pandemic—a rate significantly higher than ...

The recommendation from regulators paves the way for the shot’s approval in the European Union at a time the company is ...

Europe's medicines regulator recommended approval for Moderna's COVID and flu combination vaccine on Friday, putting it on track to become the first single shot to protect people aged 50 and older ...